Xiaodong Guo

2.9k citations
89 papers · 2.2k indexed · h-index 32
Topics
MicroRNA in disease regulation (15 papers)Cancer-related molecular mechanisms research (11 papers)Circular RNAs in diseases (10 papers)

In The Last Decade

Xiaodong Guo

85 papers receiving 2.2k citations

Peers

Xiaodong Guo
Comparison fields: 5 of 125
  • Molecular Biology 1.3k
  • Cancer Research 744
  • Epidemiology 347
  • Oncology 295
  • Surgery 232
Replace Aijuan Qu with:
Aijuan Qu China
Zhi Yang China
Ye Cheng China
Ying Lu China
Qiang Xia China
Rongxue Wu United States
Yi‐Jen Peng Taiwan
Chunyan Gu China
Lingyan Xu China
Xiaodong Guo relative to Aijuan Qu China Aijuan Qu's profile →
Citations per field
00.5×1.5×
Aijuan Qu · 1×
Citations per year

Countries citing papers authored by Xiaodong Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Guo more than expected).

Fields of papers citing papers by Xiaodong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Guo. The network helps show where Xiaodong Guo may publish in the future.

Co-authorship network of co-authors of Xiaodong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Guo. A scholar is included among the top collaborators of Xiaodong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Guo. Xiaodong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 4
3 3
4 37
5 28
6 38
7 34
8 25
9 8
10 27
11 26
12 60
13 0
14 20
15 19
16
Expression and Clinical Significance of Beclin 1 in Patients with Hepatocellular Carcinoma
2
17 26
18
Calcium overload and reactive oxygen species mediate high glucose-induced apoptosis of mouse osteoblast MC3T3-E1 cells
1
19 37
20 7

About Xiaodong Guo

Xiaodong Guo is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 89 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (744 citations), Hepatology (174 citations) and Molecular Biology (1.3k citations). Xiaodong Guo has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lu Xiong, Mei Yang, Zhiwei Li, Yanqiong Zhang, Lingxiang Yu, Lin Zou, Na Lin, Jingmin Zhao, Jingmin Zhao and Hanwei Li. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026